Literature DB >> 22802276

Virilising ovarian tumour in a woman with an adrenal nodule.

Maria Luisa Cecilia Rivera-Arkoncel1, Debby Pacquing-Songco, Frances Lina Lantion-Ang.   

Abstract

Androgen secreting tumours are the least commonly encountered androgen excess disorders, having a prevalence of 0.2%. Androblastomas of the ovary comprise less than 0.5% of all ovarian tumours. Pure Leydig cell tumours are very rare and almost always show secretion of male sex hormones. A 41-year-old multipara Filipino woman presented with a 2-year history of amenorrhoea and virilisation characterised by hirsutism, androgenic alopecia, masculine habitus and clitoromegaly. Diagnostic evaluation showed markedly elevated serum testosterone and normal dehydroepiandrosterone sulfate. Normal ovaries were seen on initial transvaginal ultrasound. A low dose dexamethasone suppression test suggested an ovarian source. A left adrenal nodule was seen on CT scan. Doppler transvaginal ultrasound revealed a solid lobulated structure in the right ovary. The patient underwent surgery and histopathology showed a Leydig cell tumour, hilar type. Serum testosterone levels normalised 3 days after surgery. Specific clinical and biochemical investigation of androgen secreting neoplasms is very important for correct diagnosis of these rare tumours.

Entities:  

Mesh:

Year:  2010        PMID: 22802276      PMCID: PMC3029143          DOI: 10.1136/bcr.07.2010.3139

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

Review 1.  Clinical practice. Hirsutism.

Authors:  Robert L Rosenfield
Journal:  N Engl J Med       Date:  2005-12-15       Impact factor: 91.245

Review 2.  American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders.

Authors:  N F Goodman; M B Bledsoe; R H Cobin; W Futterweit; J W Goldzieher; S M Petak; K D Smith; E Steinberger
Journal:  Endocr Pract       Date:  2001 Mar-Apr       Impact factor: 3.443

3.  Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism.

Authors:  E Carmina; F Rosato; A Jannì; M Rizzo; R A Longo
Journal:  J Clin Endocrinol Metab       Date:  2005-11-01       Impact factor: 5.958

4.  Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.

Authors:  L G Nardo; D W Ray; I Laing; C Williams; R J McVey; M W Seif
Journal:  Gynecol Endocrinol       Date:  2005-10       Impact factor: 2.260

5.  Intraoperative testosterone assay for virilizing ovarian tumor topographic assessment: report of a Leydig cell tumor of the ovary in a premenopausal woman with an adrenal incidentaloma.

Authors:  C Regnier; A Bennet; D Malet; T Guez; M Plantavid; P Rochaix; X Monrozies; J-P Louvet; P Caron
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

6.  The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women.

Authors:  Gregory A Kaltsas; Andrea M Isidori; Blerina P Kola; Rob H Skelly; Shern L Chew; Paul J Jenkins; John P Monson; Ashley B Grossman; G Michael Besser
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

7.  Androgen excess in women: experience with over 1000 consecutive patients.

Authors:  R Azziz; L A Sanchez; E S Knochenhauer; C Moran; J Lazenby; K C Stephens; K Taylor; L R Boots
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

8.  Sertoli-Leydig cell tumors: a clinicopathologic study of 34 cases.

Authors:  L M Roth; M C Anderson; A D Govan; F A Langley; N F Gowing; A S Woodcock
Journal:  Cancer       Date:  1981-07-01       Impact factor: 6.860

  8 in total
  4 in total

1.  Adrenal Incidentaloma Camouflaging an Ovarian Leydig Cell Tumour: A Look Beneath the Surface.

Authors:  Harsh Durgia; Sadishkumar Kamalanathan; Jayaprakash Sahoo; Murali Subbaiah; Nachiappa G Rajesh; Sagili Vijaya Bhaskar Reddy
Journal:  J Obstet Gynaecol India       Date:  2021-02-18

2.  Hyperandrogenism, insulin resistance and acanthosis nigricans (HAIR-AN syndrome): an extreme subphenotype of polycystic ovary syndrome.

Authors:  Brooke O'Brien; Rachana Dahiya; Rebecca Kimble
Journal:  BMJ Case Rep       Date:  2020-04-09

3.  Diagnostic Dilemma in Two Cases of Hyperandrogenism.

Authors:  Ibrahim Alali; Lilianne Haj Hassan; Ghadeer Mardini; Nermeen Hijazi; Lama Hadid; Younes Kabalan
Journal:  Case Rep Endocrinol       Date:  2018-06-27

Review 4.  The Masquerading, Masculinizing Tumor: A Case Report and Review of the Literature.

Authors:  Alexis LeVee; Nissi Suppogu; Christine Walsh; Wendy Sacks; James Simon; Chrisandra Shufelt
Journal:  J Womens Health (Larchmt)       Date:  2020-09-29       Impact factor: 3.017

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.